Skip to content

AVALO THERAPEUTICS, INC.: filings

Every AVALO THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 45 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026371050001534120-26-000049
10-Q2026-05-13fiscal Q1 202637790001534120-26-000033
10-K2026-03-23fiscal FY 202542850001534120-26-000011
10-Q2025-11-06fiscal Q3 2025391130001534120-25-000018
10-Q2025-08-07fiscal Q2 2025381080001628280-25-038575
10-Q2025-05-12fiscal Q1 202536770001628280-25-024436
10-K2025-03-20fiscal FY 202442870001628280-25-013986
10-Q2024-11-07fiscal Q3 2024401130001628280-24-045965
10-Q2024-08-12fiscal Q2 2024411150001628280-24-036591
10-Q/A2024-07-11fiscal Q1 202439820001628280-24-031693
10-Q2024-05-13fiscal Q1 202439820001628280-24-022763
10-K2024-03-29fiscal FY 202345910001628280-24-013786
10-Q2023-11-09fiscal Q3 2023431210001628280-23-038036
10-Q2023-08-03fiscal Q2 2023441210001628280-23-026990
10-Q2023-05-04fiscal Q1 202343910001628280-23-015703
10-K2023-03-29fiscal FY 202246910001628280-23-009630
10-Q2022-11-07fiscal Q3 2022401050001628280-22-028538
10-Q2022-08-04fiscal Q2 2022391030001628280-22-020866
10-Q2022-05-05fiscal Q1 202239830001628280-22-012436
10-K2022-03-02fiscal FY 202142870001628280-22-004671
10-Q2021-11-09fiscal Q3 2021391030001628280-21-022546
10-Q2021-08-02fiscal Q2 2021391030001628280-21-015170
10-Q2021-05-13fiscal Q1 202139820001628280-21-010083
10-K2021-03-08fiscal FY 202042860001628280-21-004162
10-Q2020-11-09fiscal Q3 2020401030001628280-20-016113
10-Q2020-08-06fiscal Q2 2020401030001628280-20-011892
10-Q2020-05-07fiscal Q1 202040840001628280-20-006935
10-K2020-03-11fiscal FY 201947890001628280-20-003395
10-Q2019-11-14fiscal Q3 2019411020001628280-19-014207
10-Q2019-08-08fiscal Q2 2019411030001628280-19-010465
10-Q2019-05-09fiscal Q1 201942860001628280-19-006439
10-K2019-03-18fiscal FY 2018501030001628280-19-003078
10-Q2018-11-13fiscal Q3 2018411070001628280-18-014190
10-Q2018-08-09fiscal Q2 201839990001628280-18-010858
10-Q2018-05-11fiscal Q1 201840830001628280-18-006658
10-K2018-04-02fiscal FY 2017481540001628280-18-003890
10-Q2017-11-07fiscal Q3 201730880001628280-17-010968
10-Q2017-08-14fiscal Q2 201722560001628280-17-008646
10-Q2017-05-09fiscal Q1 201722460001628280-17-005206
10-K2017-03-14fiscal FY 201627930001628280-17-002566
10-Q2016-11-08fiscal Q3 201623570001558370-16-009668
10-Q2016-08-15fiscal Q2 201622550001558370-16-007985
10-Q2016-05-16fiscal Q1 201622450001558370-16-006015
10-K2016-03-23fiscal FY 201525950001558370-16-004299
10-Q2015-11-13fiscal Q3 201523590001558370-15-002671

Inspect the source

Entity
AVALO THERAPEUTICS, INC. / CIK 0001534120
Captured
2026-09-20T09:16:35.394Z
SEC response SHA-256
c27cef5388033067af62e0489a1b2af90f086713b680df0f63e0f63ad2ea1ca3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001534120.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))